Sarepta Therapeutics (SRPT) Interest Coverage Ratio Growth (1y) (2018 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -27.58% |
| Sep 30, 2022 | -434.17% |
| Jun 30, 2022 | -20.23% |
| Mar 31, 2022 | 43.32% |
| Dec 31, 2021 | 58.47% |
| Sep 30, 2021 | 82.55% |
| Jun 30, 2021 | 6.85% |
| Mar 31, 2021 | -11.93% |
| Dec 31, 2020 | 42.15% |
| Sep 30, 2020 | 80.58% |
| Jun 30, 2020 | 96.52% |
| Mar 31, 2020 | 98.05% |
| Dec 31, 2019 | 54.50% |
| Sep 30, 2019 | -389.45% |
| Jun 30, 2019 | -1,511.66% |
| Mar 31, 2019 | -10,929.44% |
| Dec 31, 2018 | -1,066.12% |
| Sep 30, 2018 | 82.42% |
| Jun 30, 2018 | 91.71% |
| Mar 31, 2018 | 97.36% |